Abstract
Objective To observe the effect of ginsenoside Rg3 on the expression of vascular endothelial growth factors(VEGF)and antiangiogenesis in ectopic endometrium of rats. Methods Wistar rats endometriosis models were established referring to Jones methods, the model rats were divided into the control group, ginsenoside Rg3 group, gestrinone group, each group were divided into 2 weeks, 4 weeks, 6 weeks and 8 weeks. VEGF was observed in ectopic endometrium by immunohistochemistry(SABC technique). Results VEGF in ectopic endometrium were decreased remarkably after treatment of ginsenoside Rg3 after 2, 4, 6, 8 weeks(P 0. 05)in the gestrinone group. And with the time prolonging, the expression of VEGF was reduced remarkably(P<0. 05)while the change was not observed in the control group and the gestrinone group. Conclusion Ginsenoside Rg3 has the effect on inhibiting the expression of VEGF and angiogenesis in ectopic endometrium of rats. Ginsenoside Rg3 maybe a new drug of antiangiogenesis in ectopic endometrium. Key words: ginsenoside Rg3; endometriosis(EMs); Wistar rats; vascular endothelial growth factor(VEGF); angiogenesis
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
